Membrane Aging as the Real Culprit of Alzheimer's Disease: Modification of a Hypothesis
- PMID: 29177767
- PMCID: PMC5856718
- DOI: 10.1007/s12264-017-0192-4
Membrane Aging as the Real Culprit of Alzheimer's Disease: Modification of a Hypothesis
Abstract
Our previous studies proposed that Alzheimer's disease (AD) is a metabolic disorder and hypothesized that abnormal brain glucose metabolism inducing multiple pathophysiological cascades contributes to AD pathogenesis. Aging is one of the great significant risk factors for AD. Membrane aging is first prone to affect the function and structure of the brain by impairing glucose metabolism. We presume that risk factors of AD, including genetic factors (e.g., the apolipoprotein E ε4 allele and genetic mutations) and non-genetic factors (such as fat, diabetes, and cardiac failure) accelerate biomembrane aging and lead to the onset and development of the disease. In this review, we further modify our previous hypothesis to demonstrate "membrane aging" as an initial pathogenic factor that results in functional and structural alterations of membranes and, consequently, glucose hypometabolism and multiple pathophysiological cascades.
Keywords: Alzheimer’s disease; Amyloid-β; Membrane aging; Thiamine.
Figures

Similar articles
-
Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.Prog Neurobiol. 2013 Sep;108:21-43. doi: 10.1016/j.pneurobio.2013.06.004. Epub 2013 Jul 11. Prog Neurobiol. 2013. PMID: 23850509 Review.
-
Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.J Neurosci Res. 2017 Apr;95(4):943-972. doi: 10.1002/jnr.23777. Epub 2016 Jun 27. J Neurosci Res. 2017. PMID: 27350397 Review.
-
Hydroxyurea-induced membrane fluidity decreasing as a characterization of neuronal membrane aging in Alzheimer's disease.Aging (Albany NY). 2021 May 11;13(9):12817-12832. doi: 10.18632/aging.202949. Epub 2021 May 11. Aging (Albany NY). 2021. PMID: 33972461 Free PMC article.
-
Aging, cortical injury and Alzheimer's disease-like pathology in the guinea pig brain.Neurobiol Aging. 2014 Jun;35(6):1345-51. doi: 10.1016/j.neurobiolaging.2013.11.020. Epub 2013 Nov 27. Neurobiol Aging. 2014. PMID: 24360504
-
Understanding the cause of sporadic Alzheimer's disease.Expert Rev Neurother. 2014 Jun;14(6):621-30. doi: 10.1586/14737175.2014.915740. Expert Rev Neurother. 2014. PMID: 24852227 Review.
Cited by
-
Identification and immunological characterization of genes associated with ferroptosis in Alzheimer's disease and experimental demonstration.Mol Med Rep. 2024 Sep;30(3):155. doi: 10.3892/mmr.2024.13279. Epub 2024 Jul 4. Mol Med Rep. 2024. PMID: 38963039 Free PMC article.
-
Plasma Replacement Therapy for Alzheimer's Disease.Neurosci Bull. 2020 Jan;36(1):89-90. doi: 10.1007/s12264-019-00394-5. Epub 2019 May 20. Neurosci Bull. 2020. PMID: 31111428 Free PMC article. Review. No abstract available.
-
Clinical efficacy of sertraline in the treatment of depression caused by Alzheimer disease: A protocol of systematic review.Medicine (Baltimore). 2020 Nov 6;99(45):e23076. doi: 10.1097/MD.0000000000023076. Medicine (Baltimore). 2020. PMID: 33157972 Free PMC article.
-
TDP-43-Mediated Toxicity in HEK293T Cells: A Fast and Reproducible Protocol To Be Employed in the Search of New Therapeutic Options against Amyotrophic Lateral Sclerosis.Cells. 2019 Dec 26;9(1):68. doi: 10.3390/cells9010068. Cells. 2019. PMID: 31888078 Free PMC article.
-
Enzyme ChE, cholinergic therapy and molecular docking: Significant considerations and future perspectives.Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241289013. doi: 10.1177/03946320241289013. Int J Immunopathol Pharmacol. 2024. PMID: 39367568 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical